
LYTICS is an artificial intelligence company serving the healthcare community in solving complex medical and clinical issues with point solutions. Their focus is on chronic disease management where we collaborate with their partners in bringing game-changing, innovative and cost-efficient solutions to patients. Their company was founded on a substantial track record in applied solutions within artificial intelligence going back to the late 1980-ties. Today we manage and further develop their knowledge in our work in life science. The company Experlytics was spun off from Expertmaker in 2011, staffed from 2013 and became LYTICS in 2015.

LYTICS is an artificial intelligence company serving the healthcare community in solving complex medical and clinical issues with point solutions. Their focus is on chronic disease management where we collaborate with their partners in bringing game-changing, innovative and cost-efficient solutions to patients. Their company was founded on a substantial track record in applied solutions within artificial intelligence going back to the late 1980-ties. Today we manage and further develop their knowledge in our work in life science. The company Experlytics was spun off from Expertmaker in 2011, staffed from 2013 and became LYTICS in 2015.
Company: Lytics — customer data platform (CDP) focused on real-time profiles and personalization
Founded: Circa 2012
Headquarters: Portland, Oregon, United States
Founders: Aaron Raddon and James McDermott
Notable funding: Seed $2.2M (2013); multiple rounds including Series A (2014) and Series C
Personalized marketing and customer data unification
2012
Marketing software / Customer data platform
$2.2M
Seed round reported August 2013
Series A announced October 22, 2014
$9.2M (total reported by Feb 2016)
Total reported by Feb 2016; later rounds include a Series C led by JMI Equity per funding records
“Backed by venture investors including Voyager Capital, Rembrandt Venture Partners, Comcast Ventures and JMI Equity”